Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits
- PMID: 3994582
- DOI: 10.1161/01.atv.5.3.250
Antiatherosclerotic effects of nicardipine and nifedipine in cholesterol-fed rabbits
Abstract
Dutch-belted rabbits fed a 2% cholesterol diet for 8 weeks developed atherosclerotic lesions that covered 37.2% +/- 3.5% of the aortic luminal surface. In samples of aortic arch, accumulation of cholesterol and triglyceride was also observed. Oral administration of nicardipine or nifedipine at dosages of 40 mg/kg twice daily for 8 weeks reduced plaque area by 49.2% and 58.7%, respectively. Nicardipine and nifedipine reduced cholesterol accumulation in the aortic arch by 74.5% and 69%, respectively. Triglyceride accumulation was totally abolished. Neither drug significantly altered cholesterol concentration of plasma low density lipoprotein or high density lipoprotein, although nicardipine produced a 42% reduction in cholesterol concentration of the d less than 1.006 g/ml fraction. The above results suggest potential therapeutic utility of nicardipine in atherosclerosis.
Similar articles
-
Comparison of the antiatherosclerotic effect of tibolone with that of estradiol and ethinyl estradiol in cholesterol-fed, ovariectomized rabbits.Menopause. 2001 Summer;8(2):96-105. doi: 10.1097/00042192-200103000-00004. Menopause. 2001. PMID: 11256880
-
Ineffectiveness of Ca2+-antagonists nicardipine and diltiazem on experimental atherosclerosis in cholesterol-fed rabbits.Angiology. 1984 Oct;35(10):622-7. doi: 10.1177/000331978403501002. Angiology. 1984. PMID: 6497046
-
Suppression of atherogenesis in cholesterol-fed rabbits treated with nilvadipine, a new vasoselective calcium entry blocker.Atherosclerosis. 1989 Oct;79(2-3):147-55. doi: 10.1016/0021-9150(89)90119-6. Atherosclerosis. 1989. PMID: 2597224
-
Atherosclerosis, calcium, and calcium antagonists.Circulation. 1985 Sep;72(3):456-9. doi: 10.1161/01.cir.72.3.456. Circulation. 1985. PMID: 3893790 Review. No abstract available.
-
[Can nifedipine prevent aging of blood vessels?].Drugs. 2006;66 Spec No 1:34-6. doi: 10.2165/00003495-200666991-00013. Drugs. 2006. PMID: 18200779 Review. Japanese.
Cited by
-
Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.Drugs. 1987 Apr;33(4):296-345. doi: 10.2165/00003495-198733040-00002. Drugs. 1987. PMID: 3297616 Review.
-
Long term effects of nisoldipine on the progression of coronary atherosclerosis and the occurrence of clinical events: the NICOLE study.Heart. 2003 Aug;89(8):887-92. doi: 10.1136/heart.89.8.887. Heart. 2003. PMID: 12860866 Free PMC article. Clinical Trial.
-
Retardation of coronary artery disease in humans by the calcium-channel blocker nifedipine: results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).Cardiovasc Drugs Ther. 1990 Aug;4 Suppl 5:1047-68. doi: 10.1007/BF02018315. Cardiovasc Drugs Ther. 1990. PMID: 2076392 Clinical Trial.
-
'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.Drugs. 1987 Nov;34(5):578-98. doi: 10.2165/00003495-198734050-00005. Drugs. 1987. PMID: 3319491 Review.
-
Impact of medical therapy on atheroma volume measured by different cardiovascular imaging modalities.Cardiol Res Pract. 2010;2010:134564. doi: 10.4061/2010/134564. Epub 2010 Jul 1. Cardiol Res Pract. 2010. PMID: 20672024 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources